The Department of Social Welfare and Development said Thursday (Oct. 22) it is still awaiting the guidelines on the inclusion of the beneficiaries of Pantawid Pamilyang Pilipino Program (4Ps) in the Duterte government’s COVID-19 vaccination priority list.
“Sa ngayon po ay nais po natin linawin na ang DSWD ay hindi pa po nakakatanggap ng panuntunan o guidelines ukol dito. Kung kaya’t ang ahensya ay magsasagawa pa lang ng paghahanda kung saka sakaling magkaroon tayo ng guidelines tungkol dito,” DSWD Undersecretary Rene Glen Paje said during the virtual Laging Handa briefing.
(As of now, we want to clarify that the DSWD has yet to receive the guidelines on this. That is why the agency will conduct the necessary preparations just in case the guidelines regarding this become available.)
He said they are also awaiting the clearance from the appropriate and authorized governing agencies for the public use of the COVID-19 vaccines.
“Gayundin po hinihintay rin natin ang autorisasyon ng kaukulang ahensya upang magbigay ng clearance tungkol sa paggamit nito o kung paano ito gagamitin,” he said.
(We are also waiting the authorization from the concerned agencies that would clear the way for the public use of these vaccines and how they will be used.)
Paje appealed to 4PS beneficiaries to wait for further announcement through its various social media platforms.
As of January 31, 2020, there are more than 4.2 million “active” 4Ps beneficiaries.
Last Tuesday, DSWD spokesperson Irene Dumlao expressed the agency’s elation over President Duterte’s pronouncement last week that the 4Ps recipients will be the first to receive the coronavirus vaccines, along with the country’s security forces.
in his public address on Wednesday evening last week, President Duterte said the 4Ps beneficiaries and the security forces who are are vital in securing the country will be the first recipients of the COVID-19 vaccine. He anticipated that the vaccine is expected to arrive in the country in April 2021 at the earliest.
He announced that the Russia is committed to construct a pharmaceutical plant in the country to produce the vaccines.